Muscular Dystrophy Research Today is a free monthly online journal that collates and summarizes the latest research about Muscular Dystrophy, including details on duchenne muscular dystrophy, symptoms, treatment.

Volume 1 (2005), Issue 8 (August)

1. Protective effects of Ca2+ handling drugs against abnormal Ca2+ homeostasis and cell damage in myopathic skeletal muscle cells.
   Biochem Pharmacol, 70(5): 740-51. [Abstract] [Full-text]
2. Identification of a novel founder mutation in the DYSF gene causing clinical variability in the Spanish population.
   Arch Neurol, 62(8): 1256-9. [Abstract] [Full-text]
3. Phenotypic improvement of dystrophic muscles by rAAV/microdystrophin vectors is augmented by Igf1 codelivery.
   Mol Ther, 12(3): 441-50. [Abstract] [Full-text]
4. Cytoplasmic targeting of mutant poly(A)-binding protein nuclear 1 suppresses protein aggregation and toxicity in oculopharyngeal muscular dystrophy.
   Traffic, 6(9): 766-79. [Abstract] [Full-text]
5. Prenatal diagnosis in laminin alpha2 chain (merosin)-deficient congenital muscular dystrophy: a collective experience of five international centers.
   Neuromuscul Disord, 15(9): 588-94. [Abstract] [Full-text]
6. Genetic background influences muscular dystrophy.
   Neuromuscul Disord, 15(9): 601-9. [Abstract] [Full-text]
7. Amelioration of laminin-alpha2-deficient congenital muscular dystrophy by somatic gene transfer of miniagrin.
   Proc Natl Acad Sci U S A, 102(34): 11999-2004. [Abstract] [Full-text]
8. Coagulation system activated in Duchenne muscular dystrophy patients with cardiac dysfunction.
   Brain Dev, 27(6): 415-8. [Abstract] [Full-text]
9. A novel approach to identify Duchenne muscular dystrophy patients for aminoglycoside antibiotics therapy.
   Brain Dev, 27(6): 400-5. [Abstract] [Full-text]
10. Gene therapy flexes muscle.
    J Gene Med, 7(9): 1255-6. [Abstract] [Full-text]
11. Facioscapulohumeral dystrophy presenting as infantile facial diplegia and late-onset limb-girdle myopathy in members of the same family.
    Muscle Nerve, 32(3): 368-72. [Abstract] [Full-text]
12. A homozygous COL6A2 intron mutation causes in-frame triple-helical deletion and nonsense-mediated mRNA decay in a patient with Ullrich congenital muscular dystrophy.
    Hum Genet, 117(5): 460-6. [Abstract] [Full-text]

© 2005-2008 Muscular Dystrophy Research Today. All Rights Reserved.